異なるFOXA1変異は前立腺腫瘍形成と治療に抵抗する細胞の可塑性を誘発する
Sanjana Eyunni1,2,3, Rahul Mannan1,2, Yuping Zhang1,2
1Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Science (New York, N.Y.)
|June 26, 2025
まとめ
明確なFOXA1変異が前立腺がんの進行を促します クラス1の突然変異はアンドロゲン依存性腫瘍を促進し,クラス2の突然変異は細胞を再プログラムすることによって治療抵抗性を可能にします.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- フォークヘッドボックスA1 (FOXA1) は前立腺がんで頻繁に変化しますが,そのin vivo腫瘍性役割は不明です.
- FOXA1の機能を理解することは,標的型前立腺がん治療の開発に不可欠です.
研究 の 目的:
- 前立腺がんにおける明確なFOXA1変異のインビボ腫瘍学的メカニズムを解明する.
- 異なるFOXA1変異が腫瘍の発症と進行にどのように寄与するかを調査する.
主な方法:
- 特定のFOXA1変異のノックインマウスモデルの開発.
- 前立腺組織とオルガノイドの組織病理学的および多分子分析
- mTOR,AR,KLF5,AP-1を含む信号経路の調査
主要な成果:
- クラス1のFOXA1変異は,mTORC1/ 2とAR共活性化により,p53不活性化によるアンドロゲン依存性前立腺がんを誘発する.
- クラス2のFOXA1変異は,KLF5とAP-1を活性化させ,光細胞を再プログラムします.
- クラス2の変異は,低アンドロゲン条件下でも細胞生存と増殖を促進し,治療抵抗性を示唆する.
結論:
- FOXA1は前立腺がんにおける多面的な腫瘍遺伝子として作用する.
- 異なるFOXA1変異クラスは,腫瘍発生と治療抵抗性の進行を誘導する異なる戦略を採用しています.
関連する概念動画
01:33Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.0K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K